A detailed history of Adar1 Capital Management, LLC transactions in Pure Tech Health PLC stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 3,000 shares of PRTC stock, worth $67,650. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,000
Previous 700 328.57%
Holding current value
$67,650
Previous $17.5 Million 253.4%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.42 - $25.0 $44,666 - $57,500
2,300 Added 328.57%
3,000 $61.8 Million
Q2 2024

Aug 13, 2024

BUY
$23.78 - $32.98 $16,646 - $23,085
700 New
700 $17.5 Million

Others Institutions Holding PRTC

About PureTech Health plc


  • Ticker PRTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,888,500
  • Market Cap $629M
  • Description
  • PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...
More about PRTC
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.